Vasoactive Intestinal peptide

CAS: 40077-57-4

Ref. 3D-PP44484

Produktinformation

• Name: Vasoactive Intestinal peptide
• Synonyme: H-HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2

Beschreibung

Peptide Vasoactive Intestinal peptide is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Vasoactive Intestinal peptide include the following: Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease Y Kubota, RE Petras, CA Ottaway, RR Tubbs - Gastroenterology, 1992 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0016508592700198 Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes X Hou, D Yang, G Yang, M Li, J Zhang - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fendo.2022.984198/full Role of vasoactive intestinal peptide in osteoarthritis W Jiang, H Wang, Y Li, W Luo - Journal of Biomedical Science, 2016 - Springerhttps://link.springer.com/article/10.1186/s12929-016-0280-1 Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis VS Conlin, X Wu, C Nguyen , C Dai - American Journal , 2009 - journals.physiology.orghttps://journals.physiology.org/doi/abs/10.1152/ajpgi.90551.2008 Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension V Petkov, W Mosgoeller, R Ziesche - The Journal of , 2003 - Am Soc Clin Investighttps://www.jci.org/articles/view/17500 Osteotropic effects by the neuropeptides calcitonin gene-related peptide, substance P and vasoactive intestinal peptide UH Lerner, E Persson - J Musculoskelet Neuronal Interact, 2008 - researchgate.nethttps://www.researchgate.net/profile/Emma-Persson/publication/5230610_Osteotropic_effects_by_the_neuropeptides_calcitonin_gene-related_peptide_substance_P_and_vasoactive_intestinal_peptide/links/0c96052ab06b43037b000000/Osteotropic-effects-by-the-neuropeptides-calcitonin-gene-related-peptide-substance-P-and-vasoactive-intestinal-peptide.pdf Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor SP Sreedharan, DR Patel, JX Huang - and biophysical research , 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X8371658X Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody S Paul , DJ Volle, CM Beach, DR Johnson, MJ Powell - Science, 1989 - science.orghttps://www.science.org/doi/abs/10.1126/science.2727702 Vasoactive Intestinal Peptide-Secreting Tumors: A Review PK Siddappa , SS Vege - Pancreas, 2019 - journals.lww.comhttps://journals.lww.com/pancreasjournal/fulltext/2019/10000/vasoactive_intestinal_peptide_secreting_tumors__a.2.aspx Identification of Key Residues for Interaction of Vasoactive Intestinal Peptide with Human VPAC1 and VPAC2Receptors and Development of a Highly Selective P Nicole, L Lins , C Rouyer-Fessard, C Drouot - Journal of Biological , 2000 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)66072-2/abstract Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells MG Juarranz , B Santiago, M Torroba - , 2004 - academic.oup.comhttps://academic.oup.com/rheumatology/article-abstract/43/4/416/1784552 Vasoactive Intestinal Peptide with Isolated Intestinal Epithelial Cells from Rat: 2. Characterization and Structural Requirements of the Stimulatory Effect of Vasoactive M Laburthe, JC Prieto, B Amiranoff - European journal of , 1979 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1432-1033.1979.tb13034.x Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors M Kakurai, S Murata, H Nakagawa, N Fujita - Journal of investigative , 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022202X15412333 The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells M Delgado , E Gonzalez-Rey - The Journal of Immunology, 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/11/7311/36901 The significance of vasoactive intestinal peptide in immunomodulation M Delgado , D Pozo , D Ganea - Pharmacological reviews, 2004 - ASPEThttps://pharmrev.aspetjournals.org/content/56/2/249.short Cutting edge: is vasoactive intestinal peptide a type 2 cytokine? M Delgado , D Ganea - The Journal of Immunology, 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/166/5/2907/34621 Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions M Delgado , D Ganea - Amino acids, 2013 - Springerhttps://link.springer.com/article/10.1007/s00726-011-1184-8 Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases M Delgado , C Abad, C Martinez , M Juarranz - Journal of molecular , 2002 - Springerhttps://link.springer.com/article/10.1007/s00109-001-0291-5 Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease M Delgado , C Abad, C Martinez , J Leceta - Nature medicine, 2001 - nature.comhttps://www.nature.com/articles/nm0501_563 Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo M Delgado , A Chorny , E Gonzalez-Rey - Journal of leukocyte , 2005 - academic.oup.comhttps://academic.oup.com/jleukbio/article-abstract/78/6/1327/6922715 Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat: 1. Characterization, quantitative aspects and structural requirements of JC Prieto, M Laburthe - European Journal of , 1979 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1432-1033.1979.tb13033.x Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens J Campos-Salinas, A Cavazzuti, F O'Valle - Journal of Biological , 2014 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)38663-4/abstract The effects of vasoactive intestinal peptide in neurodegenerative disorders G Deng, L Jin - Neurological research, 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/01616412.2016.1250458 Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut F Sundler, E Ekblad, A Absood, R Haca¥kanson, K Köves - Neuroscience, 1992 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0306452292900649 The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide EM Lutz, WJ Sheward, KM West, JA Morrow - FEBS , 1993 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1016/0014-5793(93)81668-P Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells E Gonzalez-Rey , A Chorny , A Fernandez-Martin - Blood, 2006 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/107/9/3632/133492 Effect of acetylcholine and vasoactive intestinal peptide on cerebral blood flow DD Heistad, ML Marcus, SI Said - American Journal of , 1980 - journals.physiology.orghttps://journals.physiology.org/doi/abs/10.1152/ajpheart.1980.239.1.h73 Immunobiology of vasoactive intestinal peptide (VIP) D Pozo , M Delgado , C Martı́nez , JM Guerrero , J Leceta - Immunology today, 2000 - cell.comhttps://www.cell.com/trends/immunology/fulltext/S0167-5699(99)01525-X Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders CM White, S Ji , H Cai , S Maudsley - CNS & Neurological , 2010 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cnsnddt/2010/00000009/00000005/art00014 Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease C Abad, C Martinez , MG Juarranz , A Arranz , J Leceta - Gastroenterology, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0016508503000556 Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1 AJ Harmar , J Fahrenkrug, I Gozes - British journal of , 2012 - Wiley Online Libraryhttps://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1476-5381.2012.01871.x Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine A Rahmann, T Wienecke, JM Hansen - , 2008 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1111/j.1468-2982.2007.01497.x Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis A Prasse , G Zissel , N Lutzen, J Schupp - American journal of , 2010 - atsjournals.orghttps://www.atsjournals.org/doi/abs/10.1164/rccm.200909-1451OC Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders A Chorny , E Gonzalez-Rey - Proceedings of the , 2005 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0504484102 Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release A Amato, S Baldassano , R Serio - American Journal of , 2009 - journals.physiology.orghttps://journals.physiology.org/doi/abs/10.1152/ajpgi.90587.2008

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 3,325.7 g/mol
• Formel: C₁₄₇H₂₃₈N₄₄O₄₂S